Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Serum albumin has long been an essential supplement for ex vivo hematopoietic and immune cell cultures. However, serum albumin medium supplements represent a major source of biological contamination in cell cultures and often cause loss of cellular function. As serum albumin exhibits significant batch-to-batch variability, it has also been blamed for causing major issues in experimental reproducibility. We recently discovered the synthetic polymer polyvinyl alcohol (PVA) as an inexpensive, Good Manufacturing Practice-compatible, and biologically inert serum albumin replacement for ex vivo hematopoietic stem cell cultures. Importantly, PVA is free of the biological contaminants that have plagued serum albumin-based media. Here, we describe that PVA can replace serum albumin in a range of blood and immune cell cultures including cell lines, primary leukemia samples, and human T lymphocytes. PVA can even replace human serum in the generation and expansion of functional chimeric antigen receptor (CAR) T cells, offering a potentially safer and more cost-efficient approach for this clinical cell therapy. In summary, PVA represents a chemically defined, biologically inert, and inexpensive alternative to serum albumin for a range of cell cultures in hematology and immunology.

Original publication

DOI

10.1016/j.exphem.2019.11.007

Type

Journal article

Journal

Exp Hematol

Publication Date

12/2019

Volume

80

Pages

16 - 20

Keywords

Animals, Cell Culture Techniques, Cell Division, Cells, Cultured, Cytotoxicity, Immunologic, Humans, Immunotherapy, Adoptive, K562 Cells, Leukemia, Myeloid, Acute, Mice, Polyvinyl Alcohol, Receptors, Chimeric Antigen, Serum Albumin, T-Lymphocytes, Tumor Cells, Cultured